For instance, in head and neck squamous cell carcinoma, LB1, an inhibitor of protein phosphatase 2A can eliminate dormant tumor cells by promoting their activation from quiescence and increasing their sensibility to radiation or chemotherapy (136). Here, CKAP2 is linked to head and neck squamous cell carcinoma.